| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.15 | 0.01 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |